Who owns Unicycive Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Institutional ownership of UNCY from SEC Form 13F filings across 67 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 67 institutions disclosed 7.3M shares of Unicycive Therapeutics, Inc. worth $34.3M — about 27.2% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
67
13F holders
$34.3M
value, 2026 filers
27.2%
of shares outstanding (7.3M sh)
35
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of UNCY's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 1.4M | $6.6M | 0.0% | 5.3% | +3836.7% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 1.1M | $5.0M | 0.0% | 4% | -34.0% |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 564,019 | $2.6M | 0.0% | 2.1% | +176.8% |
| 4 | MARSHALL WACE, LLP | 547,862 | $2.6M | 0.0% | 2% | +253.6% |
| 5 | Diametric Capital, LP | 374,132 | $1.8M | 0.2% | 1.4% | +365.6% |
| 6 | J. Goldman & Co LPNEW | 327,345 | $1.5M | 0.0% | 1.2% | new |
| 7 | DIADEMA PARTNERS LP | 303,676 | $1.4M | 0.2% | 1.1% | +186.3% |
| 8 | MILLENNIUM MANAGEMENT LLC | 271,456 | $1.3M | 0.0% | 1% | -80.6% |
| 9 | CITIGROUP INC | 182,654 | $856,647 | 0.0% | 0.7% | +18265300.0% |
| 10 | NORTHERN TRUST CORP | 181,930 | $853,252 | 0.0% | 0.7% | +406.2% |
| 11 | VANGUARD PORTFOLIO MANAGEMENT LLCNEW | 169,196 | $793,529 | 0.0% | 0.6% | new |
| 12 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 160,039 | $750,583 | 0.0% | 0.6% | -19.7% |
| 13 | Jump Financial, LLCNEW | 153,000 | $717,570 | 0.0% | 0.6% | new |
| 14 | VANGUARD FIDUCIARY TRUST CO | 148,965 | $698,646 | 0.0% | 0.6% | +47.4% |
| 15 | GOLDMAN SACHS GROUP INC | 145,304 | $681,475 | 0.0% | 0.5% | +436.3% |
| 16 | Caption Management, LLCNEW | 110,000 | $515,900 | 0.0% | 0.4% | new |
| 17 | MORGAN STANLEY | 109,645 | $514,235 | 0.0% | 0.4% | -41.7% |
| 18 | CANTOR FITZGERALD, L. P. | 100,000 | $469,000 | 0.0% | 0.4% | +33.3% |
| 19 | LOS ANGELES CAPITAL MANAGEMENT LLCNEW | 95,019 | $445,639 | 0.0% | 0.4% | new |
| 20 | Persistent Asset Partners Ltd | 90,165 | $422,874 | 0.1% | 0.3% | +236.1% |
| 21 | Scientech Research LLCNEW | 74,490 | $349,358 | 0.3% | 0.3% | new |
| 22 | UBS Group AG | 69,377 | $325,378 | 0.0% | 0.3% | +256.8% |
| 23 | CITADEL ADVISORS LLC | 61,168 | $286,878 | 0.0% | 0.2% | -74.2% |
| 24 | Sixth Street Partners Management Company, L.P.NEW | 54,842 | $257,209 | 0.0% | 0.2% | new |
| 25 | CHARLES SCHWAB INVESTMENT MANAGEMENT INCNEW | 54,842 | $257,209 | 0.0% | 0.2% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.